# Medicamen Organ (NSE: MEDIORG) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/MEDIORG · Pivot · prices to 21 Oct 2026

Medicamen Organ (NSE: MEDIORG) closed at ₹25.45 on 21 Oct 2026. With a market capitalisation of ₹38 Cr, it ranks 3231st by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

At its last close the stock traded at 3.5× trailing earnings, against a return on equity of −14.0% in FY26. Over the past year the share price has fallen 41.8%. Its 52-week range is ₹19.10 (12 Jun 2026) to ₹38.00 (23 Oct 2025); the last close is 33.0% below the high. Promoters held 54.89% of the company as of 9 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹25.45 |
| Market cap | ₹38 Cr |
| P/E (trailing) | 3.5 |
| ROE | −14.0% (FY26) |
| ROCE | −15.3% (FY26) |
| Debt to equity | 0.5 |
| 52-week high | ₹38.00 (23 Oct 2025) |
| 52-week low | ₹19.10 (12 Jun 2026) |
| 1-year return | −41.8% |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY26 | ₹23 Cr | −₹4 Cr |
| FY25 | ₹38 Cr | ₹4 Cr |
| FY24 | ₹25 Cr | ₹3 Cr |

## Shareholding (9 Jun 2026)

- Promoters: 54.89%
- Foreign institutions: 0.05%
- Domestic institutions: 0.00%
- Non-institutions: 45.05%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [KMS Medisurgi](https://app.pivotnow.in/stock/KMSMEDI) | — | ₹43 Cr | — | — |
| [Sandu Pharma](https://app.pivotnow.in/stock/SANDUPHQ) | — | ₹41 Cr | — | — |
| [Roopa Ind](https://app.pivotnow.in/stock/ROOPAIND) | — | ₹38 Cr | — | — |
| [Lasa Supergenerics](https://app.pivotnow.in/stock/LASA) | — | ₹37 Cr | — | — |
| [JFL Life Scienc](https://app.pivotnow.in/stock/JFLLIFE) | ₹10.30 | ₹34 Cr | 0.2 | — |
| [Chandra Bhagat](https://app.pivotnow.in/stock/CBPL) | — | ₹33 Cr | — | — |

## Questions and answers

### What is the share price of Medicamen Organ today?

Medicamen Organ (NSE: MEDIORG) last closed at ₹25.45 on 21 Oct 2026. Its 52-week high is ₹38.00 and its 52-week low is ₹19.10.

### What is the market cap of Medicamen Organ?

Medicamen Organ's market capitalisation is ₹38 Cr (₹38 Cr) at the 22 Oct 2026 close, ranking 3231st among the NSE companies Pivot tracks.

### What is the P/E ratio of Medicamen Organ?

Medicamen Organ trades at a trailing P/E of 3.5.

### What is the ROE and ROCE of Medicamen Organ?

Return on equity was −14.0% in FY26 and return on capital employed was −15.3% in FY26 (consolidated figures).

### Is Medicamen Organ a debt-free company?

No. Medicamen Organ's debt-to-equity ratio was 0.5 in FY26, with total debt of ₹1 Cr.

### How has Medicamen Organ stock performed over the last year?

Medicamen Organ's share price has fallen 41.8% over the past year, +1.8% over three months and −0.8% over one month, to the 22 Oct 2026 close.

### What is the shareholding pattern of Medicamen Organ?

As of 9 Jun 2026: promoters 54.89%, foreign institutions 0.05%, domestic institutions 0.00%, non-institutions 45.05%.

### Who are Medicamen Organ's competitors?

The listed Pharma & Healthcare companies closest to Medicamen Organ by market cap are KMS Medisurgi, Sandu Pharma, Roopa Ind, Lasa Supergenerics, JFL Life Scienc and Chandra Bhagat.

### Is Medicamen Organ a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Medicamen Organ's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on MEDIORG against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.